Year |
Citation |
Score |
2024 |
Wachter A, Woodbury ME, Lombardo S, Abdourahman A, Wuest C, McGlame E, Pastika T, Tamm J, Romanul N, Yanamandra K, Bennett R, Lin G, Kwon T, Liao F, Klein C, ... ... Kummer MP, et al. Landscape of brain myeloid cell transcriptome along the spatiotemporal progression of Alzheimer's disease reveals distinct sequential responses to Aβ and tau. Acta Neuropathologica. 147: 65. PMID 38557897 DOI: 10.1007/s00401-024-02704-2 |
0.357 |
|
2021 |
Kummer MP, Ising C, Kummer C, Sarlus H, Griep A, Vieira-Saecker A, Schwartz S, Halle A, Brückner M, Händler K, Schultze JL, Beyer M, Latz E, Heneka MT. Microglial PD-1 stimulation by astrocytic PD-L1 suppresses neuroinflammation and Alzheimer's disease pathology. The Embo Journal. 40: e108662. PMID 34825707 DOI: 10.15252/embj.2021108662 |
0.492 |
|
2021 |
Rueda-Carrasco J, Martin-Bermejo MJ, Pereyra G, Mateo MI, Borroto A, Brosseron F, Kummer MP, Schwartz S, López-Atalaya JP, Alarcon B, Esteve P, Heneka MT, Bovolenta P. SFRP1 modulates astrocyte-to-microglia crosstalk in acute and chronic neuroinflammation. Embo Reports. e51696. PMID 34569685 DOI: 10.15252/embr.202051696 |
0.457 |
|
2021 |
Gerrits E, Brouwer N, Kooistra SM, Woodbury ME, Vermeiren Y, Lambourne M, Mulder J, Kummer M, Möller T, Biber K, Dunnen WFAD, De Deyn PP, Eggen BJL, Boddeke EWGM. Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease. Acta Neuropathologica. PMID 33609158 DOI: 10.1007/s00401-021-02263-w |
0.396 |
|
2019 |
Herrera-Rivero M, Santarelli F, Brosseron F, Kummer MP, Heneka MT. Dysregulation of TLR5 and TAM Ligands in the Alzheimer's Brain as Contributors to Disease Progression. Molecular Neurobiology. PMID 30852796 DOI: 10.1007/S12035-019-1540-3 |
0.633 |
|
2018 |
Rammes G, Seeser F, Mattusch K, Zhu K, Haas L, Kummer M, Heneka M, Herms J, Parsons CG. The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (Aβ) species on long-term potentiation (LTP). Neuropharmacology. PMID 30016667 DOI: 10.1016/J.Neuropharm.2018.07.021 |
0.709 |
|
2018 |
Brosseron F, Traschütz A, Widmann CN, Kummer MP, Tacik P, Santarelli F, Jessen F, Heneka MT. Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's disease. Alzheimer's Research & Therapy. 10: 25. PMID 29482610 DOI: 10.1186/S13195-018-0353-3 |
0.597 |
|
2017 |
Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, Vieira-Saecker A, Schwartz S, Santarelli F, Kummer MP, Griep A, Gelpi E, Beilharz M, Riedel D, Golenbock DT, et al. Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease. Nature. 552: 355-361. PMID 29293211 DOI: 10.1038/Nature25158 |
0.6 |
|
2017 |
Traschütz A, Kummer MP, Schwartz S, Heneka MT. Variability and temporal dynamics of novel object recognition in aging male C57BL/6 mice. Behavioural Processes. PMID 29155004 DOI: 10.1016/J.Beproc.2017.11.009 |
0.489 |
|
2017 |
Wijasa TS, Sylvester M, Brocke-Ahmadinejad N, Kummer MP, Brosseron F, Gieselmann V, Heneka MT. Proteome profiling of s-nitrosylated synaptosomal proteins by isobaric mass tags. Journal of Neuroscience Methods. PMID 28789995 DOI: 10.1016/J.Jneumeth.2017.08.005 |
0.452 |
|
2015 |
Hong GS, Schwandt T, Stein K, Schneiker B, Kummer MP, Heneka MT, Kitamura K, Kalff JC, Wehner S. Effects of macrophage-dependent peroxisome proliferator-activated receptor γ signalling on adhesion formation after abdominal surgery in an experimental model. The British Journal of Surgery. PMID 26313905 DOI: 10.1002/bjs.9907 |
0.413 |
|
2015 |
Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, ... ... Kummer MP, et al. Neuroinflammation in Alzheimer's disease. The Lancet. Neurology. 14: 388-405. PMID 25792098 DOI: 10.1016/S1474-4422(15)70016-5 |
0.593 |
|
2015 |
Krauthausen M, Kummer MP, Zimmermann J, Reyes-Irisarri E, Terwel D, Bulic B, Heneka MT, Müller M. CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model. The Journal of Clinical Investigation. 125: 365-78. PMID 25500888 DOI: 10.1172/Jci66771 |
0.667 |
|
2015 |
Kummer MP, Schwarzenberger R, Sayah-Jeanne S, Dubernet M, Walczak R, Hum DW, Schwartz S, Axt D, Heneka MT. Pan-PPAR modulation effectively protects APP/PS1 mice from amyloid deposition and cognitive deficits. Molecular Neurobiology. 51: 661-71. PMID 24838579 DOI: 10.1007/S12035-014-8743-4 |
0.632 |
|
2015 |
Hong GS, Schwandt T, Stein K, Schneiker B, Kummer MP, Heneka MT, Kitamura K, Kalff JC, Wehner S. Effects of macrophage-dependent peroxisome proliferator-activated receptor γ signalling on adhesion formation after abdominal surgery in an experimental model British Journal of Surgery. DOI: 10.1002/bjs.9907 |
0.413 |
|
2014 |
Kummer MP, Heneka MT. Truncated and modified amyloid-beta species. Alzheimer's Research & Therapy. 6: 28. PMID 25031638 DOI: 10.1186/Alzrt258 |
0.583 |
|
2014 |
Ramirez A, van der Flier WM, Herold C, Ramonet D, Heilmann S, Lewczuk P, Popp J, Lacour A, Drichel D, Louwersheimer E, Kummer MP, Cruchaga C, Hoffmann P, Teunissen C, Holstege H, et al. SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease. Human Molecular Genetics. 23: 6644-58. PMID 25027320 DOI: 10.1093/Hmg/Ddu372 |
0.562 |
|
2014 |
Kummer MP, Hammerschmidt T, Martinez A, Terwel D, Eichele G, Witten A, Figura S, Stoll M, Schwartz S, Pape HC, Schultze JL, Weinshenker D, Heneka MT, Urban I. Ear2 deletion causes early memory and learning deficits in APP/PS1 mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8845-54. PMID 24966384 DOI: 10.1523/Jneurosci.4027-13.2014 |
0.601 |
|
2014 |
Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nature Reviews. Immunology. 14: 463-77. PMID 24962261 DOI: 10.1038/Nri3705 |
0.535 |
|
2014 |
Brosseron F, Krauthausen M, Kummer M, Heneka MT. Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview. Molecular Neurobiology. 50: 534-44. PMID 24567119 DOI: 10.1007/S12035-014-8657-1 |
0.589 |
|
2014 |
Brosseron F, Kummer MP, Krauthausen M, Jessen F, Heneka M. Correlation Of Cerebrospinal Fluid Cytokines With Clinical Markers Of Dementia In Mild Cognitive Impairment And Alzheimer'S Disease Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.786 |
0.54 |
|
2014 |
Wijasa TS, Brosseron F, Kummer MP, Heneka M. Nitro-Proteomics To Discover Synaptosomal Biomarkers Of Neuroinflammation In Alzheimer'S Disease Alzheimers & Dementia. 10: 360. DOI: 10.1016/J.Jalz.2014.05.402 |
0.569 |
|
2013 |
Chalermpalanupap T, Kinkead B, Hu WT, Kummer MP, Hammerschmidt T, Heneka MT, Weinshenker D, Levey AI. Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease. Alzheimer's Research & Therapy. 5: 21. PMID 23634965 DOI: 10.1186/Alzrt175 |
0.619 |
|
2013 |
Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature. 493: 674-8. PMID 23254930 DOI: 10.1038/Nature11729 |
0.647 |
|
2013 |
Hammerschmidt T, Kummer MP, Terwel D, Martinez A, Gorji A, Pape HC, Rommelfanger KS, Schroeder JP, Stoll M, Schultze J, Weinshenker D, Heneka MT. Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice. Biological Psychiatry. 73: 454-63. PMID 22883210 DOI: 10.1016/J.Biopsych.2012.06.013 |
0.622 |
|
2013 |
Rapic S, Backes H, Viel T, Kummer MP, Monfared P, Neumaier B, Vollmar S, Hoehn M, Van der Linden A, Heneka MT, Jacobs AH. Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease. Neurobiology of Aging. 34: 351-4. PMID 22651996 DOI: 10.1016/J.Neurobiolaging.2012.04.016 |
0.591 |
|
2013 |
Delgado-Morales R, Patchev A, Llobet-Navas D, Kummer M, Heneka M, Silva J, Almeida O. Delay of Alzheimer's-like pathology in mice with 7,8-dihydroxyflavone Alzheimers & Dementia. 9: 815. DOI: 10.1016/J.Jalz.2013.05.1747 |
0.582 |
|
2012 |
Kummer MP, Vogl T, Axt D, Griep A, Vieira-Saecker A, Jessen F, Gelpi E, Roth J, Heneka MT. Mrp14 deficiency ameliorates amyloid β burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 17824-9. PMID 23223301 DOI: 10.1523/Jneurosci.1504-12.2012 |
0.672 |
|
2012 |
Yamanaka M, Ishikawa T, Griep A, Axt D, Kummer MP, Heneka MT. PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 17321-31. PMID 23197723 DOI: 10.1523/Jneurosci.1569-12.2012 |
0.642 |
|
2012 |
Kummer MP, Hülsmann C, Hermes M, Axt D, Heneka MT. Nitric oxide decreases the enzymatic activity of insulin degrading enzyme in APP/PS1 mice. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 165-72. PMID 22227962 DOI: 10.1007/S11481-011-9339-7 |
0.562 |
|
2012 |
Rey NL, Jardanhazi-Kurutz D, Terwel D, Kummer MP, Jourdan F, Didier A, Heneka MT. Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice. Neurobiology of Aging. 33: 426.e1-11. PMID 21109328 DOI: 10.1016/J.Neurobiolaging.2010.10.009 |
0.543 |
|
2012 |
Kummer M. Nitration of amyloid β in Alzheimer’s disease Nitric Oxide. 27. DOI: 10.1016/J.Niox.2012.04.013 |
0.53 |
|
2011 |
Heneka MT, Reyes-Irisarri E, Hüll M, Kummer MP. Impact and Therapeutic Potential of PPARs in Alzheimer's Disease. Current Neuropharmacology. 9: 643-50. PMID 22654722 DOI: 10.2174/157015911798376325 |
0.642 |
|
2011 |
Kummer MP, Hermes M, Delekarte A, Hammerschmidt T, Kumar S, Terwel D, Walter J, Pape HC, König S, Roeber S, Jessen F, Klockgether T, Korte M, Heneka MT. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation. Neuron. 71: 833-44. PMID 21903077 DOI: 10.1016/J.Neuron.2011.07.001 |
0.666 |
|
2011 |
Mildner A, Schlevogt B, Kierdorf K, Böttcher C, Erny D, Kummer MP, Quinn M, Brück W, Bechmann I, Heneka MT, Priller J, Prinz M. Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 11159-71. PMID 21813677 DOI: 10.1523/Jneurosci.6209-10.2011 |
0.649 |
|
2011 |
Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, ... ... Kummer MP, et al. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 386-395.e6. PMID 21784349 DOI: 10.1016/J.Jalz.2011.05.2243 |
0.551 |
|
2011 |
Terwel D, Steffensen KR, Verghese PB, Kummer MP, Gustafsson JÅ, Holtzman DM, Heneka MT. Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 7049-59. PMID 21562267 DOI: 10.1523/Jneurosci.6546-10.2011 |
0.639 |
|
2011 |
Heneka MT, Kummer MP, Weggen S, Bulic B, Multhaup G, Münter L, Hüll M, Pflanzner T, Pietrzik CU. Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer's disease. Current Alzheimer Research. 8: 115-31. PMID 21345168 DOI: 10.2174/156720511795256099 |
0.778 |
|
2011 |
Jardanhazi-Kurutz D, Kummer MP, Terwel D, Vogel K, Thiele A, Heneka MT. Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice. Neuroscience. 176: 396-407. PMID 21129451 DOI: 10.1016/J.Neuroscience.2010.11.052 |
0.605 |
|
2011 |
Perez Nievas BG, Hammerschmidt T, Kummer MP, Terwel D, Leza JC, Heneka MT. Restraint stress increases neuroinflammation independently of amyloid β levels in amyloid precursor protein/PS1 transgenic mice. Journal of Neurochemistry. 116: 43-52. PMID 21044080 DOI: 10.1111/J.1471-4159.2010.07083.X |
0.595 |
|
2010 |
Fleisher-Berkovich S, Filipovich-Rimon T, Ben-Shmuel S, Hülsmann C, Kummer MP, Heneka MT. Distinct modulation of microglial amyloid β phagocytosis and migration by neuropeptides (i). Journal of Neuroinflammation. 7: 61. PMID 20937084 DOI: 10.1186/1742-2094-7-61 |
0.54 |
|
2010 |
Heneka MT, O'Banion MK, Terwel D, Kummer MP. Neuroinflammatory processes in Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 117: 919-47. PMID 20632195 DOI: 10.1007/S00702-010-0438-Z |
0.647 |
|
2010 |
Heneka MT, Nadrigny F, Regen T, Martinez-Hernandez A, Dumitrescu-Ozimek L, Terwel D, Jardanhazi-Kurutz D, Walter J, Kirchhoff F, Hanisch UK, Kummer MP. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine. Proceedings of the National Academy of Sciences of the United States of America. 107: 6058-63. PMID 20231476 DOI: 10.1073/Pnas.0909586107 |
0.648 |
|
2010 |
Jardanhazi-Kurutz D, Kummer MP, Terwel D, Vogel K, Dyrks T, Thiele A, Heneka MT. Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits. Neurochemistry International. 57: 375-82. PMID 20144675 DOI: 10.1016/J.Neuint.2010.02.001 |
0.618 |
|
2009 |
Weberpals M, Hermes M, Hermann S, Kummer MP, Terwel D, Semmler A, Berger M, Schäfers M, Heneka MT. NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 14177-84. PMID 19906966 DOI: 10.1523/Jneurosci.3238-09.2009 |
0.515 |
|
2009 |
Papi A, Tatenhorst L, Terwel D, Hermes M, Kummer MP, Orlandi M, Heneka MT. PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models. Journal of Neurochemistry. 109: 1779-90. PMID 19457135 DOI: 10.1111/J.1471-4159.2009.06111.X |
0.487 |
|
2009 |
Kummer MP, Maruyama H, Huelsmann C, Baches S, Weggen S, Koo EH. Formation of Pmel17 amyloid is regulated by juxtamembrane metalloproteinase cleavage, and the resulting C-terminal fragment is a substrate for gamma-secretase. The Journal of Biological Chemistry. 284: 2296-306. PMID 19047044 DOI: 10.1074/Jbc.M808904200 |
0.73 |
|
2009 |
Heneka MT, Nadrigny F, Regen T, Dumitrescu-Ozimek L, Jardanhazi-Kurutz D, Terwel D, Walter J, Hanisch UK, Kirchhoff F, Kummer MP. O4-02-06: Norepinephrine modulates salutary microglial functions in transgenic models of Alzheimer's disease Alzheimer's & Dementia. 5: P153-P153. DOI: 10.1016/J.Jalz.2009.05.527 |
0.553 |
|
2009 |
Kummer MP, Hermes M, Hammerschmidt T, Terwel D, Gorji A, Pape H, Heneka MT. O1-05-07: iNOS gene deficiency modifies amyloid β
deposition, cognitive performance and hippocampal long-term potentiation in an APP transgenic mouse model Alzheimer's & Dementia. 5: P89-P89. DOI: 10.1016/J.Jalz.2009.05.229 |
0.54 |
|
2009 |
Hammerschmidt T, Terwel D, Kummer M, Weinshenker D, Gorji A, Hermann S, Schäfers M, Pape H, Heneka MT. P4-235: Norepinephrine deficiency aggravates learning and memory impairment independent of amyloid-beta levels in APP PS1 mice Alzheimer's & Dementia. 5: P499-P499. DOI: 10.1016/J.Jalz.2009.04.701 |
0.539 |
|
2008 |
Semmler A, Hermann S, Mormann F, Weberpals M, Paxian SA, Okulla T, Schäfers M, Kummer MP, Klockgether T, Heneka MT. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. Journal of Neuroinflammation. 5: 38. PMID 18793399 DOI: 10.1186/1742-2094-5-38 |
0.487 |
|
2008 |
Kummer MP, Heneka MT. PPARs in Alzheimer's Disease. Ppar Research. 2008: 403896. PMID 18645613 DOI: 10.1155/2008/403896 |
0.646 |
|
2006 |
Shaked GM, Kummer MP, Lu DC, Galvan V, Bredesen DE, Koo EH. Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1254-6. PMID 16636103 DOI: 10.1096/Fj.05-5032Fje |
0.704 |
|
2006 |
Leuchtenberger S, Kummer MP, Kukar T, Czirr E, Teusch N, Sagi SA, Berdeaux R, Pietrzik CU, Ladd TB, Golde TE, Koo EH, Weggen S. Inhibitors of Rho-kinase modulate amyloid-beta (Abeta) secretion but lack selectivity for Abeta42. Journal of Neurochemistry. 96: 355-65. PMID 16300630 DOI: 10.1111/J.1471-4159.2005.03553.X |
0.764 |
|
2004 |
Schmitz A, Schneider A, Kummer MP, Herzog V. Endoplasmic reticulum-localized amyloid beta-peptide is degraded in the cytosol by two distinct degradation pathways. Traffic (Copenhagen, Denmark). 5: 89-101. PMID 14690498 DOI: 10.1111/J.1600-0854.2004.00159.X |
0.616 |
|
2004 |
Weggen S, Berdeaux R, Kummer MP, Birkenfeld J, Sagi SS, Golde TE, Koo EH. P4-380 Inhibitors of the RHO effector RHO-kinase (rock) modulate Aβ secretion but lack selectivity for Aβ42 Neurobiology of Aging. 25: S583. DOI: 10.1016/S0197-4580(04)81938-9 |
0.703 |
|
2004 |
Kummer MP, Koo EH. P4-200 Phosphorylated C-terminal fragments of the Alzheimer precursor protein are present in caveolin-rich membrane fractions Neurobiology of Aging. 25: S532. DOI: 10.1016/S0197-4580(04)81758-5 |
0.547 |
|
2000 |
Hoffmann J, Twiesselmann C, Kummer MP, Romagnoli P, Herzog V. A possible role for the Alzheimer amyloid precursor protein in the regulation of epidermal basal cell proliferation. European Journal of Cell Biology. 79: 905-14. PMID 11152291 DOI: 10.1078/0171-9335-00117 |
0.61 |
|
2000 |
Hitzel C, Kanzler H, König A, Kummer MP, Brix K, Herzog V, Koch N. Thyroglobulin type-I-like domains in invariant chain fusion proteins mediate resistance to cathepsin L digestion. Febs Letters. 485: 67-70. PMID 11086167 DOI: 10.1016/S0014-5793(00)02189-X |
0.506 |
|
1999 |
Hoffmann J, Pietrzik CU, Kummer MP, Twiesselmann C, Bauer C, Herzog V. Binding and selective detection of the secretory N-terminal domain of the alzheimer amyloid precursor protein on cell surfaces. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 47: 373-82. PMID 10026239 DOI: 10.1177/002215549904700311 |
0.681 |
|
Show low-probability matches. |